Evidence map›Paper›PMID 32104201›Full record

ArticleComputational and mathematical methods in medicine2020

Group Guided Fused Laplacian Sparse Group Lasso for Modeling Alzheimer's Disease Progression.

Xiaoli Liu, Jianzhong Wang, Fulong Ren, Jun Kong

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xiaoli LiuCollege of Humanities and Sciences, Northeast Normal University, Changchun, China.ORCID https://orcid.org/0000-0003-2274-6180
Jianzhong WangEducation AI, College of Information Science and Technology, Northeast Normal University, Changchun, China.ORCID https://orcid.org/0000-0002-6867-3282
Fulong RenKey Laboratory of Medical Image Computing of Ministry of Education, Northeastern University, Shenyang, China.
Jun KongCollege of Humanities and Sciences, Northeast Normal University, Changchun, China.ORCID https://orcid.org/0000-0001-7095-2400
Northeast Normal University · CNNortheastern University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the largest cause of dementia, Alzheimer's disease (AD) has brought serious burdens to patients and their families, mostly in the financial, psychological, and emotional aspects. In order to assess the progression of AD and develop new treatment methods for the disease, it is essential to infer the trajectories of patients' cognitive performance over time to identify biomarkers that connect the patterns of brain atrophy and AD progression. In this article, a structured regularized regression approach termed group guided fused Laplacian sparse group Lasso (GFL-SGL) is proposed to infer disease progression by considering multiple prediction of the same cognitive scores at different time points (longitudinal analysis). The proposed GFL-SGL simultaneously exploits the interrelated structures within the MRI features and among the tasks with sparse group Lasso (SGL) norm and presents a novel group guided fused Laplacian (GFL) regularization. This combination effectively incorporates both the relatedness among multiple longitudinal time points with a general weighted (undirected) dependency graphs and useful inherent group structure in features. Furthermore, an alternating direction method of multipliers- (ADMM-) based algorithm is also derived to optimize the nonsmooth objective function of the proposed approach. Experiments on the dataset from Alzheimer's Disease Neuroimaging Initiative (ADNI) show that the proposed GFL-SGL outperformed some other state-of-the-art algorithms and effectively fused the multimodality data. The compact sets of cognition-relevant imaging biomarkers identified by our approach are consistent with the results of clinical studies.

Indexed as

Magnetic Resonance ImagingAlgorithmsAlzheimer DiseaseBiomarkersBrainCognitionCognitive DysfunctionComputer SimulationDisease ProgressionHumansImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedMachine LearningNeuroimagingRegression AnalysisBiomarkers

Identifiers

PMID32104201
PMCPMC7033952
OpenAlexW3004915343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.